Does modulating the gut hormones, incretins, modify vascular function, thereby reducing the risk of vascular complications in insulin resistant individuals? - (duplicate) (duplicate) (duplicate) (duplicate) Do the gut hormones modify vascular function in obes

niversity of Exeter0 个研究点目标入组 15 人开始时间: 2009年11月9日最近更新: 2019年11月25日

试验速览

暂无简介。

•Principal inclusion criteria: obesity (body mass index greater or equal to 30 m(2)/kg) and high risk of diabetes as defined by the Finnish Diabetes Risk Questionaire.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•diabetes, overt cardiovascular disease, Raynauds disease, renal impairment, hepatic impairment (aminotransferase or aspartate aminotransferase > 3 times the upper limit of normal), hypersensitivity to Vildagliptin or any of its excipents (eg anhydrous lactose) and current treatment with any anti-hypertensive, oral hypoglycaemic or lipid lowering therapies.

发起方

niversity of Exeter